⌘K

Login Start Free

Home/Filings/4/0001127602-24-014470

4//SEC Filing

SAGAN PAUL 4

Accession 0001127602-24-014470

CIK 0001682852other

View on SEC.gov Company Profile

Filed

May 6, 8:00 PM ET

Accepted

May 7, 4:59 PM ET

Size

5.2 KB

Accession

0001127602-24-014470

Insider Transaction Report

Form 4

Period: 2024-05-06

Moderna, Inc.MRNA

Director

Transactions

Award
Stock Option (Right to Buy)
2024-05-06+7,557→ 7,557 total
Exercise: $122.13Exp: 2034-05-06→ Common Stock (7,557 underlying)

Footnotes (1)

[F1]This option will become fully vested and exercisable on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Moderna, Inc.

CIK 0001682852

Entity typeother

Related Parties

1

filerCIK 0001035440

Filing Metadata

Form type: 4
Filed: May 6, 8:00 PM ET
Accepted: May 7, 4:59 PM ET
Size: 5.2 KB

View on SEC.gov